Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05422586 · ClinicalTrials.gov registry record
Way To Drive Validation Study
A clinical trial of Distracted Driving and Driving Behaviors, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 62
- Enrollment target
- 1
- Study location
NCT05422586: Completed study of Distracted Driving and Driving Behaviors, sponsored by University of Pennsylvania.
NCT05422586 is a study of Distracted Driving and Driving Behaviors that has completed, run by University of Pennsylvania. The registered enrollment target is 62 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05422586, a study of Distracted Driving and Driving Behaviors, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
Way to Drive is a smart phone-based driving telematics application. Research participants are invited to download the app, which uses phone sensors to track driving behaviors including mileage, hard breaking events, and handheld phone use while driving, measured as the phone screen being unlocked while the phone is in the hand and the vehicle is in motion. Before the study team launches a clinical trial using the app, the researchers will test its capabilities and reliability.
Primary Outcome
Measured by the driving and behavior when the car is in motion by the Way to Drive app.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2022-07-17 |
| Est. Completion | 2022-08-13 |
What the finished NCT05422586 record still lists
NCT05422586 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 3 conditions, with Distracted Driving appearing as the primary indexed condition, and to 0 interventions.
NCT05422586 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05422586 about?
NCT05422586 is a clinical study titled "Way To Drive Validation Study". Way to Drive is a smart phone-based driving telematics application. Research participants are invited to download the app, which uses phone sensors to track driving behaviors including mileage, hard breaking events, and handheld phone use while driving, measured as the phone screen being unlocked wh...
What is the current status of trial NCT05422586?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2022-07-17. Estimated completion is 2022-08-13.
What conditions does trial NCT05422586 study?
This clinical trial studies the following conditions: Distracted Driving, Driving Behaviors, Validity.
Who is sponsoring clinical trial NCT05422586?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05422586 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Distracted Driving
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI